<p>The invention provides: (1) novel sodium-containing omeprazole salts formed by the reaction of omeprazole and a sodium source in a crystallization solvent; (2) novel zinc-containing omeprazole salts formed by the reaction of omeprazole and a zinc source in a crystallization solvent, including salts formed by the recrystallization of a zinc salt in a reaction mixture comprising a sodium-containing omeprazole salt and a crystallization solvent ; and (3) methods of treatment which use the novel salts to treat or prevent gastric acid-related diseases.</p>
申请公布号
WO2006073779(A1)
申请公布日期
2006.07.13
申请号
WO2005US45944
申请日期
2005.12.15
申请人
TRANSFORM PHAMACEUTICALS, INC.;HICKEY, MAGALI, BOURGHOL;PETERSON, MATTHEW